HALOZYME THERAPEUTICS INC's ticker is HALO and the CUSIP is 40637H109. A total of 177 filers reported holding HALOZYME THERAPEUTICS INC in Q4 2016. The put-call ratio across all filers is 1.62 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $590,104 | -62.6% | 14,797 | -62.3% | 0.00% | -55.6% |
| Q4 2021 | $1,578,243 | -82.6% | 39,250 | -80.4% | 0.01% | -84.2% |
| Q2 2021 | $9,082,000 | +274.2% | 200,000 | +41.5% | 0.06% | +216.7% |
| Q2 2019 | $2,427,000 | +1327.6% | 141,300 | +1300.7% | 0.02% | +1700.0% |
| Q2 2018 | $170,000 | -59.1% | 10,088 | -50.9% | 0.00% | -50.0% |
| Q4 2017 | $416,000 | +35.9% | 20,537 | +16.7% | 0.00% | 0.0% |
| Q3 2017 | $306,000 | +76.9% | 17,600 | +0.5% | 0.00% | +100.0% |
| Q4 2016 | $173,000 | +46.6% | 17,511 | +40.1% | 0.00% | 0.0% |
| Q1 2016 | $118,000 | -91.1% | 12,500 | -85.9% | 0.00% | -87.5% |
| Q4 2013 | $1,326,000 | +827.3% | 88,486 | +582.4% | 0.01% | +700.0% |
| Q3 2013 | $143,000 | – | 12,966 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TRAN CAPITAL MANAGEMENT, L.P. | 1,084,118 | $61,686,285 | 7.80% |
| SNYDER CAPITAL MANAGEMENT L P | 3,983,814 | $226,679,017 | 5.12% |
| First Light Asset Management, LLC | 923,119 | $52,525,471 | 4.88% |
| Redwood Investments, LLC | 441,809 | $25,138,932 | 3.37% |
| BERNZOTT CAPITAL ADVISORS | 444,728 | $25,305,023 | 3.27% |
| DOHENY ASSET MANAGEMENT /CA | 46,050 | $2,620 | 3.04% |
| Crawford Lake Capital Management, LLC | 42,171 | $2,399,530 | 2.75% |
| 2Xideas AG | 416,586 | $23,703,743 | 2.51% |
| Granite Investment Partners, LLC | 902,882 | $51,373,986 | 2.14% |
| HighMark Wealth Management LLC | 41,790 | $2,377,851 | 1.79% |